<?xml version="1.0" encoding="UTF-8"?>
<p id="Par7">Recently, several fungal disease outbreaks have been noted worldwide, ranging from keratitis in contact lens wearers to health careâ€“associated fungal infections with high mortality [
 <xref ref-type="bibr" rid="CR14">14</xref>]. Even as both invasive fungal infections and fungal resistance to currently limited antifungal drugs are becoming more common, and there are several molecules being studied for a number of fungal diseases [
 <xref ref-type="bibr" rid="CR15">15</xref>], there have not been any new antifungals approved for use in the USA since our last review in 2017. Some strains of 
 <italic>Candida glabrata</italic> and 
 <italic>auris</italic> implicated in disseminated disease are now multidrug resistant [
 <xref ref-type="bibr" rid="CR16">16</xref>].
</p>
